Lung cancer in 'never-smokers': beyond EGFR mutations and EGFR-TK inhibitors

Oncology (Williston Park). 2010 Jan;24(1):48-9.
No abstract available

Publication types

  • Review
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Clinical Trials as Topic
  • Enzyme Inhibitors / therapeutic use
  • ErbB Receptors / genetics
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / genetics*
  • Mutation
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Smoking / adverse effects

Substances

  • Antineoplastic Agents
  • Enzyme Inhibitors
  • ErbB Receptors
  • Protein-Tyrosine Kinases